Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

Matthew I. Milowsky, Christian Dittrich, Ignacio Durán, Satinder Jagdev, Frederick Millard, Christopher J. Sweeney, Dean F. Bajorin, Linda Cerbone, David I. Quinn, Walter M. Stadler,

European Journal of Cancer · 2014 · 113 citations · 18 references

Concepts

References

18